Dr Hongjian Qin | Synthetic Chemistry | Best Researcher Award |
Shanghai Institute of Materia Medica, CAS, China
Professional Profiles:
👨🎓 Bio Summary:
Dr. Hongjian Qin is an accomplished researcher and innovator in sustainable and green chemistry, specializing in organic process development and pharmaceutical synthesis. Currently serving as a Research Director at Topharman Company Limited in Shanghai, China, he is committed to advancing environmentally friendly and efficient methods in drug development. With a proven track record in academia and industry, Dr. Qin has contributed extensively to the synthesis of key pharmaceutical intermediates, emphasizing scalability and sustainability.
🎓 Educational Background:
Dr. Qin holds a Ph.D. in Organic Chemistry (2024) from the Chinese Academy of Sciences, with a focus on process development of drug substances and medicinal administration. He earned a Master of Engineering (2006) and a Bachelor of Science (2003) in Organic Chemistry from Guangxi University, where he laid the foundation for his expertise in synthetic chemistry.
🔍 Research Focus:
Dr. Qin’s research centers on the development of sustainable chemical processes, particularly for pharmaceutical applications. His work includes optimizing synthesis pathways, creating ligand-free catalytic systems, and exploring green methodologies for large-scale drug production. He has advanced innovative solutions for synthesizing intermediates for critical drugs like telmisartan, nirmatrelvir, and sildenafil, contributing to the reduction of environmental impact in chemical manufacturing.
🏆 Honors & Awards:
Dr. Qin was recognized as an “Excellent Graduate Student” during his Ph.D. studies at the University of Chinese Academy of Sciences, a testament to his academic excellence and dedication to research innovation.
💼 Professional Experience:
As Research Director at Topharman Company Limited since 2024, Dr. Qin leads drug process development and pharmaceutical synthesis initiatives. He collaborates with multidisciplinary teams to develop sustainable solutions for drug manufacturing, bridging the gap between academic research and industrial application.
📚 Top Noted Publications :
Title: Direct Esterification of Amides by the Dimethylsulfate-Mediated Activation of Amide C–N Bonds
Authors: Qin, H.; Han, Z.; Bonku, E.M.; … Shen, J.; Aisa, H.A.
Citations: 0
Index: Communications Chemistry
Year: 2024
Title: An Alternative Approach to Synthesize Sildenafil via Improved Copper-Catalyzed Cyclization
Authors: Odilov, A.; Gong, X.; Qin, H.; … Yang, F.; Shen, J.
Citations: 0
Index: Journal of Organic Chemistry
Year: 2024
Title: Impurity Study of Tecovirimat
Authors: Bonku, E.M.; Qin, H.; Odilov, A.; … Wang, X.; Shen, J.
Citations: 1
Index: Heliyon
Year: 2024
Title: An Improved Iodine-Catalyzed Aromatization Reaction and Its Application in the Synthesis of a Key Intermediate of Cannabidiol
Authors: Abduahadi, S.; Mintah Bonku, E.; Qin, H.; … Aisa, H.A.; Shen, J.
Citations: 0
Index: Synlett
Year: 2024
Title: Improved and Ligand-Free Copper-Catalyzed Cyclization for an Efficient Synthesis of Benzimidazoles from o-Bromoarylamine and Nitriles
Authors: Bonku, E.M.; Qin, H.; Odilov, A.; … Aisa, H.A.; Shen, J.
Citations: 2
Index: RSC Advances
Year: 2024
Conclusion:
Dr. Hongjian Qin is a highly promising candidate for the “Best Researcher Award,” with a strong foundation in sustainable and green chemistry, an impressive publication record, and impactful industry-relevant work. His innovative approaches in synthetic chemistry demonstrate significant academic and practical value.
To strengthen his candidacy further, Dr. Qin could focus on:
Gaining broader recognition through high-impact conferences and leadership in major collaborative projects.
Highlighting mentorship roles and contributions to the research community.
Securing competitive grants and leading interdisciplinary research initiatives.
Overall, his accomplishments, combined with ongoing efforts to expand his influence and visibility, make him a strong contender for this prestigious recognition.